Ohcanbohtosat - B. Neyns

  • Čájehuvvo 1 - 4 / 4
Aiddostahte ozu
Listu   Galleriija  
  1. 1

    Add-on of anti-PD-1 therapy to BRAF/MEK inhibition in patients with poor-prognosis stage IV BRAFV600-mutant melanoma, a retrospective case series Dahkki C. Bertels, D. Talhaoui, I. Dirven, B. Neyns

    Almmustuhtton 2026-01-01
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2

    Exploratory study on the effectiveness of integrative neurocognitive remediation therapy (iNCRT) for cancer survivors Dahkki A. Rogiers, D. Kyndt, S. Van Eycken, J.-C. Le Febvre, M. Brohee, C. Degols, C. Fontaine, B. Neyns, C. Kornreich

    Almmustuhtton 2022-06-01
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3

    Differentiation between normal and metastatic lymph nodes in patients with skin melanoma: Preliminary findings using a DIXON-based whole-body MRI approach Dahkki C. Brussaard, L. Faggioni, F.E. Ramirez-Barbosa, M. Vervoort, Y. Jansen, B. Neyns, J. de Mey, I. Willekens, D. Cioni, E. Neri

    Almmustuhtton 2024-06-01
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4

    Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting Dahkki L. Mortier, R. Gutzmer, V. Atkinson, S. Dalle, P. Saiag, B. Neyns, A. Rorive, P. Parente, M. Weichenthal, J.-J. Grob, C. Lebbé, P. Mohr, T. Eigentler, L. McDonald, L. Willemot, F. Brellier, O. Bakharevski, S. Houssou, M. Jadhao, D. Schadendorf

    Almmustuhtton 2024-01-01
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: